Results
1 -
10 of
30
(Click
here to explore results)
- Neglected Diseases and Drug Discovery, Chapter 9 Current Approaches to Tuberculosis Drug Discovery and Development. Mark J. Mitton-Fry, Debra Hanna
, 2012
, Pages 228-261
- New Horizons in Predictive Toxicology: Current Status and Application, Chapter 12 Predicting Drug-Induced Mitochondrial Dysfunction. Sashi Nadanaciva, Yvonne Will
, 2012
, Pages 283-306
- Neglected Diseases and Drug Discovery, Chapter 13 Drug Discovery for Lower Respiratory Tract Infections. J Carl Craft
, 2012
, Pages 366-411
- Antibiotic Drug Discovery: New Targets and Molecular Entities, Subject Index
, 2017
, Pages 256-271
- Antibiotic Drug Discovery: New Targets and Molecular Entities, CHAPTER 4 Narrow Spectrum Antibacterial Agents. Lauren A. Spagnuolo, Peter J. Tonge, Stewart L. Fisher
, 2017
, Pages 76-102
- Polysaccharide-based Biomaterials: Delivery of Therapeutics and Biomedical Applications, Chapter 13 Xanthan Gum in Drug Carriers. Rimpy, Rashmi, Munish Ahuja
, 2023
, Pages 361-396
- Biological Interactions with Surface Charge in Biomaterials, Chapter 13 Community- and Hospital-acquired Staphylococcal Infections. R. Thornton, J. Cooney
, 2012
, Pages 175-192
- Drug Discovery from Natural Products, Chapter 14 Natural Products: New Agents Against MDR Tuberculosis. Ujjini Manjunatha*, Fumiaki Yokokawa, Meera Gurumurthy, Thomas Dick
, 2012
, Pages 307-325
- Natural Product Chemistry for Drug Discovery, Chapter 14 Daptomycin. Richard H. Baltz
, 2009
, Pages 395-409
- Drug Discovery from Natural Products, Chapter 12 Discovery and Development of Platensimycin and Platencin. Sheo Singh
, 2012
, Pages 249-277